Neuphoria Therapeutics Inc. – Common Stock (NASDAQ:NEUP – Get Free Report) issued its quarterly earnings data on Friday. The company reported ($1.23) EPS for the quarter, beating the consensus estimate of ($2.01) by $0.78, Zacks reports.
Neuphoria Therapeutics Inc. – Common Stock Stock Up 5.2 %
Neuphoria Therapeutics Inc. – Common Stock stock traded up $0.24 during midday trading on Friday, reaching $4.84. The company had a trading volume of 61,450 shares, compared to its average volume of 1,079,810. Neuphoria Therapeutics Inc. – Common Stock has a 12-month low of $2.12 and a 12-month high of $15.96.
Wall Street Analyst Weigh In
Separately, HC Wainwright raised their target price on shares of Neuphoria Therapeutics Inc. – Common Stock from $8.00 to $21.00 and gave the stock a “buy” rating in a report on Tuesday, February 4th.
About Neuphoria Therapeutics Inc. – Common Stock
Neuphoria Therapeutics, Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.
Featured Articles
- Five stocks we like better than Neuphoria Therapeutics Inc. – Common Stock
- CD Calculator: Certificate of Deposit Calculator
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- EV Stocks and How to Profit from Them
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for Neuphoria Therapeutics Inc. - Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuphoria Therapeutics Inc. - Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
